# Role of Montelukast in Asthma and Allergic Rhinitis Patients

> **NCT03380975** · PHASE4 · COMPLETED · sponsor: **Clinision** · enrollment: 600 (actual)

## Conditions studied

- Asthma and Allergic Rhinitis

## Interventions

- **DRUG:** Montelukast 10mg

## Key facts

- **NCT ID:** NCT03380975
- **Lead sponsor:** Clinision
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-28
- **Primary completion:** 2019-03-25
- **Final completion:** 2019-06-30
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2020-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03380975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03380975, "Role of Montelukast in Asthma and Allergic Rhinitis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03380975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*